Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Biogen,Fampridine,Symptomatic walking improvement for people with MS,Fampridine,Recommended for decline,Community and Hospital,Musculoskeletal System
